Cramer: Johnson & Johnson's stock stands out in the crowded race for a coronavirus vaccine

CNBC's Jim Cramer said Thursday that Johnson & Johnson has the most promising stock of the companies that are developing a vaccine to prevent Covid-19.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.